Vectra DA
Jump to navigation
Jump to search
Contraindications
- monitoring disease activity in rheumatoid arthritis*
* at baseline, Vectra DA results mirrored validated clinical measures of disease activity. However, at 3 months, 1 year, & 2 years, no association was found between Vectra DA scores & disease activity or radiographic progression[1]
Principle
- unknown
- measures 12 different biomarkers
Notes
More general terms
References
- ↑ 1.0 1.1 1.2 Fleischmann R, Connolly SE, Maldonado MA, Schiff M Brief report: Estimating disease activity using multi-biomarker disease activity scores in rheumatoid arthritis patients treated with abatacept or adalimumab. Arthritis Rheumatol 2016 Sep; 68:2083 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27111089 <Internet> http://onlinelibrary.wiley.com/doi/10.1002/art.39714/abstract